Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:focusArea |
HIV/AIDS
mental health quality assurance diabetes telemedicine biotechnology cardiology clinical trials medical devices neurology oncology pediatrics rare diseases supply chain management antibiotics chronic diseases market access clinical research orthopedics vaccines dermatology preventive healthcare cardiovascular diseases global health initiatives immunology pain management pharmacovigilance women's health respiratory diseases patient support programs sustainability in healthcare diagnostics geriatrics healthcare education urology gastroenterology acute diseases regulatory affairs pharmaceutical marketing anti-infectives lifestyle diseases healthcare_policy_advocacy healthcare_technology healthcare_consulting |
| gptkbp:founded |
2007
|
| gptkbp:headquarters |
gptkb:London,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cipla UK Limited
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:operatesIn |
gptkb:United_Kingdom
|
| gptkbp:parentCompany |
gptkb:Cipla_Limited
|
| gptkbp:products |
generic drugs
|
| gptkbp:services |
healthcare_solutions
|
| gptkbp:website |
www.cipla.com
|